Claus‐Michael Lehr

31.1k citations

417 papers · 22.0k indexed · 2 hit papers · h-index 81

Impact in

Pharmaceutical Science top 0.01%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery

Papers in

Pharmaceutical Science 154
- Advanced Drug Delivery Systems 99
- Advancements in Transdermal Drug Delivery 57
- Drug Solubulity and Delivery Systems 33
Molecular Medicine 21

Co-authors: Ulrich F. Schaefer Hans E. Junginger Udo Bakowsky Marc Schneider Alf Lamprecht Eva-Maria Collnot Brigitta Loretz Joke A. Bouwstra
Journals: European Journal of Pharmaceutics and Biopharmaceutics (47 papers)Journal of Controlled Release (40 papers)International Journal of Pharmaceutics (28 papers)Pharmaceutical Research (24 papers)Advanced Drug Delivery Reviews (13 papers)
Partner nations: Germany United States France

In The Last Decade

Claus‐Michael Lehr

403 papers receiving 21.4k citations

Hit Papers

align trajectories log scale

Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane 2021 · 230 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Communications Biology
1992 International Journal of Pharmaceutics

Peers

Countries citing papers authored by Claus‐Michael Lehr

Since Specialization

Citations

This map shows the geographic impact of Claus‐Michael Lehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus‐Michael Lehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus‐Michael Lehr more than expected).

Fields of papers citing papers by Claus‐Michael Lehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus‐Michael Lehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus‐Michael Lehr. The network helps show where Claus‐Michael Lehr may publish in the future.

Co-authors

The 25 scholars most cited alongside Claus‐Michael Lehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claus‐Michael Lehr Line = papers co-authored together Claus‐Michael Lehr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen ChemMedChem ·Aylin Berwanger, Saskia C. Stein, Sarah Brandner, Andreas M. Kany, Sebastian Heinz, Brigitta Loretz, Claus‐Michael Lehr, Anna K. H. Hirsch, Frederik Lermyte, Thomas F. Schulz, Martin Empting	2025	0
2	The role of ABC transporters in the human lung epithelium—insights from and limitations of current in vitro cell models PubMed ·Silke Simon, Carina Cantrill, Claus‐Michael Lehr	2025	1
3	Tobramycin crosslinking improves the colloidal stability of arginine chitosan biodynamers for safe and efficient siRNA delivery International Journal of Biological Macromolecules ·Yun Liu, Achim Biesel, Mohamed A. M. Kamal, Lorenz Latta, Brigitta Loretz, Anna K. H. Hirsch, Sangeun Lee, Claus‐Michael Lehr	2025	0
4	Antibiotic resistance and tolerance: What can drug delivery do against this global threat? Drug Delivery and Translational Research ·Juan Aparicio-Blanco, Nikhar Vishwakarma, Claus‐Michael Lehr, Clive A. Prestidge, Nicky Thomas, Richard J. Roberts, Chelsea R. Thorn, Ana Melero	2024	17
5	Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier Drug Delivery and Translational Research ·Sarah Nasr, Pascal Paul, Brigitta Loretz, Claus‐Michael Lehr	2024	4
6	Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations International Journal of Pharmaceutics ·Tim A. Schöner, Verena Vogel, Márta Venczel, Katharina Knoth, Walter Kamm, Tobias Paehler, Guillaume Louit, Iria Torres Terán, Patricia Mundinger, Alexander Marker, Petra Loos, Marius Hittinger, Claus‐Michael Lehr	2024	5
7	3D bioprinting of E. coli MG1655 biofilms on human lung epithelial cells for building complex in vitro infection models Biofabrication ·Samy Aliyazdi, Sarah Frisch, Alberto Hidalgo, Nicolas Frank, Daniel Krug, Rolf Müller, Ulrich F. Schaefer, Thomas Vogt, Brigitta Loretz, Claus‐Michael Lehr	2023	14
8	Cell‐Derived Vesicles for Antibiotic Delivery—Understanding the Challenges of a Biogenic Carrier System Small ·Eilien Heinrich, Olga Hartwig, Christine Walt, Arefeh Kardani, Marcus Koch, Leila Pourtalebi Jahromi, Jessica Hoppstädter, Alexandra K. Kiemer, Brigitta Loretz, Claus‐Michael Lehr, Gregor Fuhrmann	2023	10
9	Anti-Inflammatory and Antinociceptive Activity of Herbal Lipospheres of Pentaclethra macrophylla (Fabaceae) Stem Bark Extract Processes ·Petra O. Nnamani, Edith Obioma Diovu, Ikechukwu Emmanuel Peter, Akachukwu Marytheresa Onwuka, Chiamaka Victory Ogbuanwu, Obiora Emmanuel Abonyi, Brigitta Loretz, Claus‐Michael Lehr	2023	2
10	Formulation of benznidazole-lipid nanocapsules: Drug release, permeability, biocompatibility, and stability studies International Journal of Pharmaceutics ·Eva Carolina Arrúa, Olga Hartwig, Brigitta Loretz, Xabier Murgia, Duy‐Khiet Ho, Guillaume Bastiat, Claus‐Michael Lehr, Claudio J. Salomón	2023	15
11	Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties Advanced Drug Delivery Reviews ·Benedikt C. Huck, Xabier Murgia, Sarah Frisch, Marius Hittinger, Alberto Hidalgo, Brigitta Loretz, Claus‐Michael Lehr	2022	31
12	Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers Pharmaceutical Research ·Eva Carolina Arrúa, Olga Hartwig, Duy‐Khiet Ho, Brigitta Loretz, Xabier Murgia, Claudio J. Salomón, Claus‐Michael Lehr	2021	11
13	Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems Pharmaceutics ·Sarah Nasr, Sangeun Lee, Durairaj Thiyagarajan, Annette Boese, Brigitta Loretz, Claus‐Michael Lehr	2021	18
14	Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies Drug Discovery Today ·Carlos Victor Montefusco-Pereira, Cristiane de Souza Carvalho‐Wodarz, Johanna Seeger, Charlotte Kloft, Robin Michelet, Claus‐Michael Lehr	2020	6
15	IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia American Journal of Physiology-Lung Cellular and Molecular Physiology ·Lisa Wolf, Sandra Sapich, Anja Honecker, Christopher Jungnickel, Frederik Seiler, Markus Bischoff, Bodo Wonnenberg, Christian Herr, Nicole Schneider‐Daum, Claus‐Michael Lehr, Robert Bals, Christoph Beißwenger	2016	33
16	miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity Proceedings of the National Academy of Sciences ·Isabelle Serr, Rainer W. Fürst, Verena B. Ott, Martin G. Scherm, Alexei Nikolaev, Füsun Gökmen, Stefanie Kälin, Stephanie Zillmer, Melanie Bunk, Benno Weigmann, Nicole Kunschke, Brigitta Loretz, Claus‐Michael Lehr, Benedikt Kirchner, Bettina Haase, Michael W. Pfaffl, Ari Waisman, Richard A. Willis, Anette‐G. Ziegler, Carolin Daniel	2016	48
17	Tight junctions form a barrier in porcine hair follicles European Journal of Cell Biology ·Christiane Mathes, Johanna M. Brandner, Michael Laue, Simon Sebastian Raesch, Steffi Hansen, Antonio Virgilio Failla, Sabine Vidal, Ingrid Moll, Ulrich F. Schaefer, Claus‐Michael Lehr	2015	21
18	In vitro skin absorption of butyl methoxydibenzoylmethane determined in human epidermis and in a reconstituted human epidermis model OpenAgrar ·Sindy Trauer, Helena Kanďárová, E. L. Schmidt, Dieter Traue, Unlrich F Schaefer, Claus‐Michael Lehr, Manfred Liebsch	2006	1
19	Investigating the Sugar-Lectin Interaction by Computational Chemistry: Tunneling the Epithelial Barrier Max Planck Institute for Plasma Physics ·Dirk Neumann, Elleonore Haltner, Claus‐Michael Lehr, Oliver Kohlbacher, Hans‐Peter Lenhof	1998	1
20	Release of a peptide drug from microspheres of poly(2-hydroxyethyl-methacrylate) relevant for the development of an oral bioadhesive drug delivery system European Journal of Pharmaceutics and Biopharmaceutics ·Claus‐Michael Lehr, J.A. Bouwstra, Don A. van Hal, J. Coos Verhoef, Hans E. Junginger	1992	7

About Claus‐Michael Lehr

Claus‐Michael Lehr is a scholar working on Pharmaceutical Science, Molecular Medicine, Dermatology, Biomaterials and Pulmonary and Respiratory Medicine, having authored 417 papers that have together received 22.0k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (100 papers), Advanced Drug Delivery Systems (99 papers), RNA Interference and Gene Delivery (60 papers), Advancements in Transdermal Drug Delivery (57 papers), Nanoparticle-Based Drug Delivery (39 papers), Advanced biosensing and bioanalysis techniques (36 papers), Drug Solubulity and Delivery Systems (33 papers) and Dermatology and Skin Diseases (31 papers). The work is most often cited by research in Pharmaceutical Science (8.9k citations), Biomaterials (4.3k citations), Molecular Medicine (1.0k citations), Dermatology (1.5k citations) and Pulmonary and Respiratory Medicine (4.1k citations). Claus‐Michael Lehr has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Ulrich F. Schaefer, Hans E. Junginger, Udo Bakowsky, Marc Schneider, Alf Lamprecht, Eva-Maria Collnot, Brigitta Loretz, Joke A. Bouwstra, Nicole Schneider‐Daum and Ulrich Schäfer. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Journal of Controlled Release, International Journal of Pharmaceutics, Pharmaceutical Research and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact